An archived webcast will be available following the event.
Trial milestone reached: Alpha Tau completed enrolment of 88 patients in its US ReSTART trial for recurrent skin cancer, a key step toward possible FDA pre-market approval. New planning technology: GE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results